The effect of forced expression of mutatedK-RASgene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy-Reference-Cited by-同舟云学术

The effect of forced expression of mutatedK-RASgene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy

Published:2016-06-23 Issue:2 Volume:56 Page:515-526
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol. Carcinog.

Author:

Matsunaga Yasutaka¹,Adachi Yasushi¹²,Sasaki Yasushi³,Koide Hideyuki¹,Motoya Masayo¹,Nosho Katsuhiko¹,Takagi Hideyasu¹,Yamamoto Hiroyuki⁴,Sasaki Shigeru¹,Arimura Yoshiaki¹,Tokino Takashi³,Carbone David P.⁵,Imai Kohzoh⁶,Shinomura Yasuhisa¹

Affiliation:

1. Department of Gastroenterology, Rheumatology and Clinical Immunology; Sapporo Medical University; Sapporo Japan

2. Sapporo Shirakaba-Dai Hospital; Sapporo Japan

3. Medical Genome Sciences, Research Institute of Frontier Medicine; Sapporo Medical University; Sapporo Japan

4. Division of Gastroenterology and Hepatology, Department of Internal Medicine; St. Marianna University School of Medicine; Kawasaki Japan

5. James Cancer Center; The Ohio State University Medical Center; Columbus Ohio

6. The Institute of Medical Science Hospital; The University of Tokyo; Tokyo Japan

Funder

Ministry of Health, Labour and Welfare

Ono Cancer Research Fund

Japanese Society of Strategies for Cancer Research and Therapy

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Reference51 articles.

1. 2015 http://wwwcancerorg/acs/groups/content/@editorial/documents/document/acspc-044552pdf

2. http://ganjohojp/professional/statistics/statisticshtml#mortality 2014

3. Oncogenes and the strategy of growth factors;Baserga;Cell,1994

4. Insulin-like growth factor-I receptor as a candidate for a novel molecular target in the gastrointestinal cancers;Adachi;Dig Endosc,2006

5. The insulin-like growth factor I receptor: A key to tumor growth;Baserga;Cancer Res,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumoral RNA ‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies;Cancer Science;2022-07-11

2. Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma;Journal of Hematology & Oncology;2019-07-24

3. Circulating insulin‐like growth factor binding protein‐3 and risk of gastrointestinal malignant tumors;Journal of Gastroenterology and Hepatology;2019-07-24

4. IGF-I regulates HT1080 fibrosarcoma cell migration through a syndecan-2/Erk/ezrin signaling axis;Experimental Cell Research;2017-12